Structure of Lorlatinib
CAS No.: 1454846-35-5
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Lorlatinib (PF-06463922) is a selective, orally active, brain-penetrant, ATP-competitive ROS1/ALK inhibitor with anticancer activity, having Kis of <0.025 nM, <0.07 nM, and 0.7 nM for ROS1, wild-type ALK, and ALKL1196M, respectively. Lorlatinib targets EML4-ALK and inhibits ALK phosphorylation with IC50s of 15-43 nM (ALKL1196), 14-80 nM (ALKG1269A), 38-50 nM (ALK1151Tins), and 77-113 nM (ALKG1202R).
Synonyms: PF-06463922; PF-6463922
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 1454846-35-5 |
Formula : | C21H19FN6O2 |
M.W : | 406.41 |
SMILES Code : | N#CC1=C(C2=CN=C(C(O[C@@H](C3=CC(F)=CC=C3C4=O)C)=C2)N)C(CN4C)=NN1C |
Synonyms : |
PF-06463922; PF-6463922
|
MDL No. : | MFCD28144520 |
InChI Key : | IIXWYSCJSQVBQM-LLVKDONJSA-N |
Pubchem ID : | 71731823 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302 |
Precautionary Statements: | P280-P305+P351+P338 |
Target |
|
In Vitro:
Concentration | Treated Time | Description | References |
Ba/F3 cells | 300, 600, 1000 nM | 2-4 weeks | Identify lorlatinib-resistant ALK compound mutations | PMC6441848 |
Ba/F3 cells | 300, 600, 1000 nM | 2-4 weeks | Through ENU mutagenesis screening, lorlatinib-resistant ALK compound mutations were identified, including compound mutations of I1171N and G1202R. | PMC6441848 |
Ba/F3 cells | 10, 100, 300, 600, 1000 nM | 3 h | The inhibitory effect of lorlatinib on the ALK-G1202R + G1269A double mutation was evaluated, and the results showed that this mutation was resistant to lorlatinib. | PMC6441848 |
NCI-H3122 | 4 µM | 2–4 months | To study the evolution of resistance to different ALK inhibitors in NCI-H3122 cells, it was found that Lorlatinib could select for cells with strong resistance to high concentrations of ALK inhibitors. | PMC7224215 |
JFCR-028-3-LR1000#1 | 1 or 3 µM | 1 week | To establish Lorlatinib-resistant cell models and study their cross-resistance to Lorlatinib and other ALK-TKIs. | PMC8931094 |
JFCR-028-3 cells | 100 nM | 9 days | To evaluate the effect of Lorlatinib on JFCR-028-3 cells, it was found that MIG6 depletion increased resistance to ALK-TKIs. | PMC10807714 |
In Vivo:
Administration | Dosage | Frequency | Description | References |
BALB-c nu/nu mice | JFCR-041-2 cell xenograft model | Oral | 10 mg/kg | Once daily for 5-6 days/week | Investigate lorlatinib resistance mechanisms | PMC6441848 |
mouse | EML4-ALK L1196M | intraperitoneal injection | 0.5, 2, 10 mg/kg | daily for 2 weeks | Lorlatinib suppressed ALK-driven tumor growth in a dose-dependent manner, but LUSC showed significant resistance to lorlatinib treatment | PMC10824105 |
BALB/c nu/nu mice | Mouse model of EML4-ALK-G1202R mutation | Oral | 10, 30, 50 mg/kg | Once daily for 5-6 days/week | In the mouse model of EML4-ALK-G1202R mutation, lorlatinib initially significantly shrank the tumor, but the tumor eventually regrew, and the ALK-G1202R + G1269A double mutation was identified. | PMC6441848 |
mouse | EML4-ALK L1196M model | intraperitoneal injection | 0.5, 2, 10 mg/kg | daily for 2 weeks | To investigate the inhibitory effect of Lorlatinib on tumors in the EML4-ALK L1196M mouse model, it was found that Lorlatinib dose-dependently suppressed ALK-driven tumor growth, with LUAD showing significant decrease in tumor sizes at 0.5 and 2 mg/kg Lorlatinib treatments, while LUSC showed no significant change. | PMC10824105 |
NOD/SCID gamma mice | Subcutaneous xenograft model | Oral | 3 mg/kg | Once daily, 4 days on, 3 days off | Evaluate the inhibitory effect of lorlatinib alone or in combination with selumetinib on ROS1 fusion-positive tumors. | PMC8034819 |
mice | NSG mice | oral | 6 mg/kg | daily administration for 3 weeks | To evaluate the therapeutic efficacy of Lorlatinib in ALK-positive NSCLC in vivo, it was found that Lorlatinib significantly inhibited tumor growth. | PMC7224215 |
BALB/c nude mice | JFCR-028-3 cell xenograft model | Oral | 10 mg/kg | 5 days per week for 4 weeks | To evaluate the antitumor effect of Lorlatinib in vivo on JFCR-028-3 cell xenograft model, it was found that MIG6 depletion conferred resistance to ALK-TKIs, and combination therapy could overcome the resistance. | PMC10807714 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT05167500 | Metastatic Non Small Cell Lung... More >> Cancer Less << | COMPLETED | 2022-12-30 | Hospital Clínico Santiago, San... More >>tiago De Compostela, A Coru?a, 15706, Spain|Hospital Universitario Central de Asturias, Oviedo, Asturias, 33011, Spain|Hospital Germans Trias i Pujol, Badalona, Barcelona, 08916, Spain|Hospital Puerta del Mar, Cadiz, Cádiz, 11009, Spain|Hospital Universitario Insular de Gran canaria, Las Palmas De Gran Canaria, Gran Canaria, 35016, Spain|Complejo Hospitalario Universitario A Coru?a, A Coru?a, La Coru?a, 15006, Spain|Centro Oncológico de Galicia, A Coru?a, La Coru?a, 15009, Spain|Hospital del Mar, Barcelona, 08003, Spain|Hospital Universitari Quiron Dexeus, Barcelona, 08028, Spain|Hospital Clinic de Barcelona, Barcelona, 08036, Spain|Hospital Universitario de Burgos, Burgos, 09006, Spain|Hospital Dr. Josep Trueta, Girona, 17007, Spain|Hospital Universitario de Jaén, Jaén, 23007, Spain|Complejo Asistencial Universitario de León, León, 24071, Spain|Hospital Gregorio Mara?ón, Madrid, 28007, Spain|Hospital Clínico San Carlos, Madrid, 28040, Spain|Hospital 12 De Octubre, Madrid, 28041, Spain|Hospital Puerta de Hierro, Madrid, 28222, Spain|Hospital Fundación de Alcorcón, Madrid, 28922, Spain|Hospital Virgen del Rocio, Sevilla, 41013, Spain|Complejo Hospitalario de Toledo, Toledo, 45004, Spain|Hospital Universitari i Politécnic La Fe, Valencia, 46009, Spain|Hospital Clínico de Valencia, Valencia, 46010, Spain|Hospital General de Valencia, Valencia, 46014, Spain|Hospital Clínico Lozano Blesa, Zaragoza, 50009, Spain Less << | |
NCT06282874 | Carcinoma, Non-Small-Cell Lung... More >>|Brain Metastases|Leptomeningeal Metastasis Less << | PHASE4 | NOT_YET_RECRUITING | 2027-03-01 | Guangdong Provincial Perople's... More >> Hospital, Guangzhou, Other (Non U.s.), 510080, China Less << |
NCT04621188 | Non Small Cell Lung Cancer Met... More >>astatic Less << | PHASE2 | RECRUITING | 2025-01-26 | Centre Hospitalier du Pays d'A... More >>ix, Aix-en-Provence, 13616, France|Centre Paul Papin, Angers, 49055, France|Angers - CHU, Angers, France|Annecy - CH, Annecy, France|Antony - H?pital privé, Antony, France|Avignon - CH, Avignon, France|Centre Hospitalier de la C?te Basque, Bayonne, 64100, France|Bordeaux - CHU, Bordeaux, France|Bordeaux - Institut Bergonie, Bordeaux, France|Bordeaux - Polyclinique, Bordeaux, France|AP-HP H?pital Ambroise Paré, Boulogne, 92104, France|Caen - CHU C?te de Nacre, Caen, 14000, France|Chauny - CH, Chauny, France|Cholet - CH, Cholet, France|Clermont-Ferrand - CHU, Clermont-Ferrand, France|Colmar - CH, Colmar, France|Centre Hospitalier Intercommunal de Créteil, Créteil, 94000, France|Dijon - CRLCC, Dijon, France|CHRU Grenoble, Grenoble, France|Centre Hospitalier - Pneumologie, Le Mans, 72000, France|H?pital Calmette, Lille, 59037, France|Centre Léon Bérard, Lyon, 69373, France|Institut Paoli Calmettes, Marseille, 13273, France|Marseille H?pital Nord, Marseille, 13915, France|GRH Mulhouse Sud-Alsace, Mulhouse, France|AP-HP H?pital Cochin, Paris, 75014, France|AP-HP Hopital Tenon - Pneumologie, Paris, 75020, France|AP-HP H?pital Bichat, Paris, 75877, France|Paris - Curie, Paris, France|Lyon - URCOT, Pierre-Bénite, France|Rouen - CHU, Rouen, France|Nouvel H?pital Civil - H?pitaux Universitaires de Strasbourg, Strasbourg, 67091, France|H?pital Foch, Suresnes, 92151, France|CHU Toulouse - Pneumologie, Toulouse, France|CHU Bretonneau, Tours, 37044, France|Valenciennes - Clinique, Valenciennes, France|Vandoeuvre-lès-Nancy - CHU, Vand?uvre-lès-Nancy, France Less << |
NCT06378892 | Non Small Cell Lung Cancer Met... More >>astatic|ALK Gene Mutation Less << | PHASE2 | RECRUITING | 2025-05-28 | Centro di Riferimento Oncologi... More >>co (CRO) IRCCS, Aviano, 33081, Italy|Azienda Ospedaliero-Universitaria Careggi Oncologia Medica, Firenze, 50134, Italy|Azienda USL Toscana Nord Ovest Oncologia Medica, Ospedale Versilia, Lido Di Camaiore, 55049, Italy|Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino amadori", Meldola, 47014, Italy|Fondazione IRCCS San Gerardo dei Tintori, Monza, 20900, Italy|IOV Istituto Oncologico Veneto IRCCS, Padova, 35128, Italy|Azienda Ospedaliero-Universitaria di Parma, Parma, 43126, Italy|Azienda Ospedaliera di Perugia, Perugia, 06129, Italy|Azienda Sanitaria Universitaria Friuli Centrale (ASU FC), Udine, 33010, Italy Less << |
NCT05740943 | Stage III NSCLC|Surgery | PHASE2 | RECRUITING | 2026-12-31 | Guangdong Provincial People's ... More >>Hospital, Guangzhou, Guangdong, 510080, China Less << |
NCT06410040 | ALK-positive Non-small Cell Lu... More >>ng Cancer|Brain Metastases|Meningeal Metastasis Less << | ACTIVE_NOT_RECRUITING | 2024-06-30 | Sichuan cancer hospital, Cheng... More >>du, Sichuan, 610000, China Less << | |
NCT02927340 | Non-Small Cell Lung Cancer (NS... More >>CLC) Less << | PHASE2 | UNKNOWN | 2025-05-23 | Massachusetts general Hospital... More >>, Boston, Massachusetts, 02114, United States Less << |
NCT04111705 | Non Small Cell Lung Cancer Met... More >>astatic Less << | PHASE2 | ACTIVE_NOT_RECRUITING | 2025-01-25 | Angers - CHU, Angers, France|A... More >>nnecy - CH, Annecy, France|Bayonne - CH, Bayonne, France|Besan?on - CHU, Besan?on, France|Bordeaux - CHU H?pital Haut-Lévèque, Bordeaux, France|Boulogne - Ambroise Paré, Boulogne-Billancourt, France|Caen - CHU C?te de Nacre, Caen, 14000, France|Colmar - CH, Colmar, France|Créteil - CHI, Créteil, France|Dijon - CRLCC, Dijon, France|Grenoble - CHU, Grenoble, France|Le Mans - CHG, Le Mans, France|Lille - H?pital Calmette, Lille, France|Lyon - CRLCC, Lyon, France|Marseille - AP-HM H?pital Nord, Marseille, France|Marseille - Institut Paoli Calmette, Marseille, France|Montpellier - CHU, Montpellier, France|Montpellier - Clinique, Montpellier, France|Mulhouse - GHRMSA, Mulhouse, France|Nantes - CRLCC, Nantes, France|Orléans - CHR, Orléans, 45000, France|Paris - APHP - Hopital Tenon, Paris, 75020, France|Paris - APHP Bichat, Paris, France|Paris - Curie, Paris, France|Paris - H?pital Cochin, Paris, France|Lyon - URCOT, Pierre-Bénite, France|Saint Quentin - CH, Saint Quentin, 02100, France|Strasbourg - Nouvel H?pital Civil, Strasbourg, France|Suresnes - Hopital Foch, Suresnes, 92151, France|Toulon - CHI, Toulon, 83000, France|Toulouse - CHU, Toulouse, France|Vandoeuvre-lès-Nancy - CRLCC, Vandoeuvre-lès-Nancy, France Less << |
NCT05144997 | Non-Small-Cell Lung Cancer|NSC... More >>LC Less << | PHASE4 | ACTIVE_NOT_RECRUITING | 2026-12-28 | UC Irvine Health, Orange, Cali... More >>fornia, 92868-3201, United States|The First affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, China|Beijing Chest Hospital, Capital Medical University, Beijing, Beijing, 100000, China|Beijing Cancer Hospital, Beijing, Beijing, 100142, China|Fujian Cancer Hospital, Fuzhou, Fujian, 350014, China|Guangdong Provincial People's Hospital, Guangzhou, Guangdong, 510080, China|Hunan Cancer Hospital, Changsha, Hunan, 410006, China|General Hospital of Eastern Theater Command, Nanjing, Jiangsu, 210002, China|The first hospital of jilin university, Changchun City, Jilin, 130021, China|Jilin Cancer Hospital, Changchun, Jilin, 130000, China|Jilin Cancer Hospital, Changchun, Jilin, 130028, China|Sir Run Shaw Hospital, Hangzhou, Qiantang District, 310016, China|The Second Affiliated Hospital of PLA Air Force Medical University, Xi'an City, Shaanxi, 710038, China|Shanghai Chest Hospital, Shanghai, Shanghai, 200030, China|Sichuan Cancer Hospital, Chengdu, Sichuan, 610000, China|Sichuan Cancer Hospital, Chengdu, Sichuan, 610041, China|The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China|The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, Zhejiang, 310009, China|Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, China|The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, Zhejiang, 310052, China|University Cancer Hospital, Beijing, 100000, China|Beijing Chest Hospital, Capital Medical University, Beijing, 101149, China|Fudan University Shanghai Cancer Center, Shanghai, 200032, China|CHU de Rennes - H?pital Pontchaillou, Rennes, 35033, France|Institut Gustave Roussy, Villejuif Cedex, 94805, France|Healthcare Global Enterprises, Bengaluru, Karnataka, 560027, India|Bhakti Vedanta Hospital & Research Institute, Thane/Mumbai, Maharashtra, 401107, India|Bhaktivedanta Hospital & Research Institute, Thane, Maharashtra, 401107, India|Aichi Cancer Center Hospital, Nagoya, Aichi, 464-8681, Japan|National University Hospital, Singapore, 119074, Singapore|National Cancer Centre Singapore, Singapore, 168583, Singapore|National Cancer Centre Singapore, Singapore, 169610, Singapore|Hospital Vall D′Hebron, Barcelona, Catalu?a, 08035, Spain|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain|National Taiwan University Hospital, Taipei, 10002, Taiwan Less << |
NCT03542305 | Renal Impairment | PHASE1 | COMPLETED | 2020-02-20 | Anaheim Clinical Trials, LLC, ... More >>Anaheim, California, 92801, United States|Prism Clinical Research, LLC, Saint Paul, Minnesota, 55114, United States Less << |
NCT05297890 | Advanced or Metastatic ROS1-Po... More >>sitive Non-Small Cell Lung Cancer Less << | PHASE2 | ACTIVE_NOT_RECRUITING | 2025-11-25 | Guangdong Provincial People's ... More >>hospital, Guangzhou, Guangdong, 510080, China|Beijing Cancer Hospital, Beijing, China|Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China|The First Hospital of Jilin University, Changchun, China|Hunan Cancer Hospital, Changsha, China|Sichuan Cancer Hospital & Institute, Chengdu, China|West China Hospital of Sichuan University, Chengdu, China|Chinese PLA Army Medical Center, Chongqing, China|Fujian Cancer Hospital, Fuzhou, China|Sun Yat-sen University Cancer Center, Guangzhou, China|The first Affiliated hospital, Sun Yat-Sen University, Guangzhou, China|Zhejiang Cancer Hospital, Hangzhou, China|Harbin Medical University Cancer Hospital, Harbin, China|The First Affiliated Hospital of Anhui Medical University, Hefei, China|Shandong Cancer Hospital&Institute, Jinan, China|Yunnan Cancer Hospital, Kunming, China|The First Affiliated Hospital of Nanchang University, Nanchang, China|The Second Affiliated Hospital of Nanchang University, Nanchang, China|Jiangsu Province Hospital, Nanjing, China|Fudan University Shanghai Cancer Center, Shanghai, China|Shanghai Pulmonary Hospital, Shanghai, China|Liaoning Cancer Hospital and Institute, Shenyang, China|Shanxi Cancer hospital, Taiyuan, China|Tianjin Medical University Cancer Institute & Hospital, Tianjin, China|The 1st Affiliated hospital of Wenzhou Medical University, Wenzhou, China|Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China|Tangdu Hospital of The fourth Military Medical University Peoples Liberation Army of China, Xi'an, China|Xiamen Humanity Hospital, Xiamen, China|Henan Cancer Hospital, Zhengzhou, China|Henan Provincial People's Hospital, Zhengzhou, China|The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China Less << |
NCT06487078 | ALK+ Non-Small-Cell Lung Carci... More >>noma Less << | NOT_YET_RECRUITING | 2028-11-30 | - | |
NCT05224609 | Moderate Hepatic Impairment|Se... More >>vere Hepatic Impairment|Healthy Volunteers Less << | PHASE1 | COMPLETED | 2024-08-13 | Orange County Research Center,... More >> Tustin, California, 92780, United States|Genesis Clinical Research, LLC, Tampa, Florida, 33603, United States|Prism Research LLC dba Nucleus Network, Saint Paul, Minnesota, 55114, United States Less << |
NCT03439215 | Carcinoma, Non-Small-Cell Lung | PHASE2 | UNKNOWN | 2025-06-22 | IRCCS - Istituto Scientifico R... More >>omagnolo per lo Studio e la Cura dei Tumori (IRST)- Oncologia Medica, Meldola, Forlì- Cesena, 47014, Italy|Sacro Cuore- Don Calabria Hospital- U.O.C. Oncologia Medica, Negrar, Verona, 37024, Italy|Istituto Toscano Tumori Ospedale San Donato- U.O.C. di Oncologia Medica Dipartimento di Oncologia USL-8, Arezzo, 52100, Italy|Azienda Ospedaliera di Rilievo Nazionale "S.G. Moscati", Avellino, 83100, Italy|IRCCS Istituto Tumori Giovanni Paolo II, Bari, 70124, Italy|IRCCS A.O.U. San Martino- IST- Istituto Nazionale per la Ricerca sul Cancro- U.O.S. Tumori Polmonari, Genova, 16132, Italy|Istituto Europeo di Oncologia - Divisione di Oncologia Toracica, Milano, 20141, Italy|A.O.U. Policlinico di Modena- Oncologia Ematologia e Malattie Apparato Respiratorio, Modena, 41124, Italy|A.O. San Gerardo, Monza, 20900, Italy|Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, 80131, Italy|Istituto Oncologico Veneto IRCCS- UOS Oncologia Toracica UOC. Oncologia Medica 2, Padova, 35128, Italy|Casa di Cura La Maddalena- U.O. Oncologia medica, Palermo, 90146, Italy|Azienda Ospedaliera Universitaria di Parma- Struttura Complessa di Oncologia Medica, Parma, 43126, Italy|Azienda Ospedaliera di Perugia- S.C. Oncologia Medica, Perugia, 06132, Italy|Ospedale di Ravenna- Oncologia Medica, Ravenna, 48121, Italy|Ospedale "Infermi" Rimini, Rimini, 47900, Italy|ASST della Valle Olona - Ospedale di Saronno, Saronno, 21047, Italy|A.O.U. San Luigi Gonzaga, Torino, 10043, Italy|Azienda ULSS 9 TREVISO-UOC Oncologia Medica, Treviso, 31100, Italy|Policlinico 'G.B.Rossi' Borgo Roma - A.O.U. Integrata (Giampaolo Tortora)- Oncologia Medica, Verona, 37134, Italy Less << |
NCT03178071 | Non Small Cell Lung Cancer ALK... More >> Positive or ROS1 Positive Less << | NO_LONGER_AVAILABLE | - | Arizona Oncology Associates, P... More >>C - NAHOA, Sedona, Arizona, 86336, United States|Pacific Shores Medical Group, Huntington Beach, California, 92648, United States|Pacific Shores Medical Group, Irvine, California, 92618, United States|Pacific Shores Medical Group, Long Beach, California, 90808, United States|Pacific Shores Medical Group, Long Beach, California, 90813, United States|Kaiser Permanente, Oakland Medical Center, Oakland, California, 94611, United States|UC Irvine Health / Chao Family Comprehensive Cancer Center, Orange, California, 92868, United States|University of California Irvine/Chao Family Comprehensive Cancer Center, Orange, California, 92868, United States|Kaiser Permanente, South Sacramento Medical Center, Sacramento, California, 95823, United States|Kaiser Permanente, San Francisco Medical Center, San Francisco, California, 94115, United States|Kaiser Permanente, Vallejo Medical Center, Vallejo, California, 94589, United States|Memorial Cancer Institute at Memorial Hospital West, Pembroke Pines, Florida, 33028, United States|University Cancer & Blood Center, Llc, Athens, Georgia, 30607, United States|University of Chicago Medical Center, CCD, Chicago, Illinois, 60637, United States|University of Chicago Medical Center, Chicago, Illinois, 60637, United States|Elmhurst Memorial Hospital Nancy W. Knowles Cancer Center, Elmhurst, Illinois, 60126, United States|Edward Cancer Center, Naperville, Illinois, 60540, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States|Dana Farber Cancer Institute/Pharmacy, Boston, Massachusetts, 02215, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109, United States|Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Henry Ford Health System, Detroit, Michigan, 48202, United States|Henry Ford Hospital, Detroit, Michigan, 48202, United States|Karmanos Cancer Institute Weisberg Cancer Treatment Center, Farmington Hills, Michigan, 48334, United States|Siteman Cancer Center - West County, Creve Coeur, Missouri, 63141, United States|Washington University School of Medicine, Saint Louis, Missouri, 63110, United States|Siteman Cancer Center - South County, Saint Louis, Missouri, 63129, United States|Siteman Cancer Center - St Peters, Saint Peters, Missouri, 63376, United States|Rutgers Cancer Institute Of New Jersey, New Brunswick, New Jersey, 08903, United States|North Shore Hematology Oncology Associates, East Setauket, New York, 11733, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10022, United States|Breast and Imaging Center - 12th floor, New York, New York, 10065, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|North Shore Hematology Oncology Associates, Patchogue, New York, 11772, United States|North Shore Hematology Oncology Associates, Port Jefferson Station, New York, 11776, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, 45219, United States|Ohio State University East Hospital, Columbus, Ohio, 43205, United States|The Ohio State University Investigational Drug Services, Columbus, Ohio, 43210, United States|The Ohio State University James Cancer Hospital, Columbus, Ohio, 43210, United States|The Ohio State University, Columbus, Ohio, 43210, United States|Stefanie Spielman Comprehensive Breast Center, Columbus, Ohio, 43212, United States|The Ohio State University Martha Morehouse Medical Plaza, Columbus, Ohio, 43221, United States|CarePoint Gahanna, Gahanna, Ohio, 43230, United States|UPMC Hillman Cancer Center - Patient Clinic, Pittsburgh, Pennsylvania, 15232, United States|Charleston Hematology Oncology Associates, PA, Charleston, South Carolina, 29414, United States|Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas, 75246, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States Less << | |
NCT04127110 | Non Small Cell Lung Cancer | PHASE2 | ACTIVE_NOT_RECRUITING | 2025-11-24 | Institut Jules Bordet-Hopital ... More >>Universitaire ULB, Brussels, 1000, Belgium|Cliniques Universitaires Saint-Luc, Brussels, BE 1200, Belgium|Universitair Ziekenhuis Antwerpen, Edegem, BE 2650, Belgium|CHU-UCL Namur - CHU Mont Godinne - UCL Namur, Yvoir, 5530, Belgium|Centre Hospitalier Avignon, Avignon, 84902, France|Assistance Publique Hopitaux Paris - Hopital Avicenne, Bobigny, France|CHU de Brest, Brest, 29200, France|Centre Hopitalier Intercommunal De Creteil, Créteil, 94010, France|Gustave Roussy, Villejuif, France|King Hussein Cancer Center, Amman, Jordan|The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam, 1066 CX, Netherlands|Academisch Ziekenhuis Maastricht, Maastricht, Netherlands|Erasmus MC, Rotterdam, Netherlands|Oslo University Hospital - Radiumhospitalet, Oslo, Norway|Institut Catala d'Oncologia - ICO L'Hospitalet - Hospital Duran i Reynals, Hospitalet De Llobregat, Barcelona, 08908, Spain|Hospital Clinic Universitari de Barcelona, Barcelona, Spain|Hospital De La Santa Creu I Sant Pau, Barcelona, Spain|Institut Catala d'Oncologia - ICO Badalona - Hospital Germans Trias i Pujol, Barcelona, Spain|Hospital General Universitario Gregorio Maranon, Madrid, 28007, Spain|Clinica Universidad de Navarra - Clinica Universitaria De Navarra, Madrid, Spain|Hospital Universitario 12 De Octubre, Madrid, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital Universitari Son Espases, Palma De Mallorca, Spain|Clinica Universidad de Navarra - Clinica Universitaria De Navarra, Pamplona, Spain|University Hospital Virgen del Rocio, Sevilla, Spain|The Christie NHS Foundation Trust, Manchester, United Kingdom Less << |
NCT06678555 | Carcinoma, Non-Small-Cell Lung | NOT_YET_RECRUITING | 2025-09-30 | Pfizer, Taipei, Taiwan | |
NCT06361589 | ALK-positive Non-small Cell Lu... More >>ng Cancer|Real World Study Less << | RECRUITING | 2028-11-01 | Sichuan cancer hospital, Cheng... More >>du, Sichuan, 610000, China Less << | |
NCT04541706 | Advanced Non-Small Cell Lung C... More >>ancer Less << | PHASE4 | COMPLETED | 2022-07-20 | Rajiv Gandhi Cancer Institute ... More >>And Research Centre, New Delhi, Delhi, 110085, India|The Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, 380016, India|Hemato Oncology Clinic Ahmedabad Pvt. Ltd, Ahmedabad, Gujarat, 380054, India|Artemis hospital, Gurugram, Haryana, 122001, India|National Cancer Institute, Nagpur, Maharashtra, 441108, India|Apex Wellness Hospital, Nashik, Maharashtra, 422009, India|Grant Medical Foundation, Ruby Hall Clinic, Pune, Maharashtra, 411001, India|Sahyadri Clinical Research and Development Center, Pune, Maharashtra, 411004, India|Sahyadri Super Speciality Hospital, Pune, Maharashtra, 411004, India|Bhaktivedanta Hospital and Research Institute, Thane, Maharashtra, 401107, India|Yashoda Hospital, Hyderabad, Telangana State, 500082, India|Tata Medical Center, Kolkata, WEST Bengal, 700160, India Less << |
NCT03127618 | - | APPROVED_FOR_MARKETING | - | - | |
NCT03909971 | Carcinoma, Non-Small-Cell Lung | PHASE2 | COMPLETED | 2024-10-21 | Gaoxin Hospital of The First A... More >>ffilated Hospital of Anhui Medical University, Hefei, Anhui, 230088, China|Beijing Cancer Hospital, Beijing, Beijing, 100142, China|Fujian Province Oncology Hospital, Fuzhou, Fujian, 350014, China|Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, 150081, China|Hunan Provincial Tumor Hospital/Division of Oncology, Changsha, Hunan, 410013, China|The first hospital of jilin university, Changchun, Jilin, 130021, China|Jilin Provincial Cancer Hospital, Changchun, Jilin, 130103, China|Tangdu Hospital of Fourth Military Medical University, Xi'an, Shanxi, 710000, China|Sichuan Province Cancer Hospital/Department of Pulmonary Tumor, Chengdu, Sichuan, 610041, China|West China Hospital, Sichuan University, Cancer center, Chengdu, Sichuan, 610041, China|The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, Zhejiang, 310009, China|Sir Run Run Shaw Hospital of College of Medicine of Zhejiang University, Center for Oncology, Hangzhou, Zhejiang, 310016, China|Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, China|Fifth Medical Center of PLA General Hospital, Beijing, 100071, China|Beijing Chest Hospital, Capital Medical University, Beijing, 101149, China|Guangdong Provincial People's Hospital, Guangzhou, 510000, China|The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China|General Hospital of Eastern Theater Command, Nanjing, Jiangsu, China|Shanghai Chest Hospital, Shanghai, 200030, China|Fudan University Shanghai Cancer Center, Shanghai, 200032, China|Zhongshan Hospital, Fudan University, Shanghai, 200032, China Less << |
NCT03505554 | Anaplastic Large Cell Lymphoma... More >>, ALK-Positive Less << | PHASE2 | RECRUITING | 2025-12-24 | Asst-Monza, Monza, Italy/MB, 2... More >>0900, Italy|UOC Ematologia, Ospedale S. Eugenio, Roma, Italy Less << |
NCT03612154 | Nonsmall Cell Lung Cancer | PHASE2 | UNKNOWN | 2023-12-31 | National Cancer Center, Goyang... More >>-Si, Gyeonggi-do, 10408, Korea, Republic of Less << |
NCT04362072 | Carcinoma|Non-Small-Cell Lung | PHASE4 | COMPLETED | 2024-10-23 | UCI Medical Center/Chao Family... More >> Comprehensive Cancer Center, Orange, California, 92868, United States|University Cancer & Blood Center, Llc, Athens, Georgia, 30607, United States|Rajiv Gandhi Cancer Institute And Research Centre, New Delhi, Delhi, 110085, India|Rajiv Gandhi Cancer Institute And Research Centre, New Delhi, DEL, 110085, India|Medanta-The Medicity, Gurgaon, Haryana, 122001, India|Healthcare Global Enterprises, Bengaluru, Karnataka, 560027, India|Bhakti Vedanta Hospital and Research Institute, Thane, Maharashtra, 401107, India|Fondazione IRCCS San Gerardo dei Tintori, Monza, Lombardia, 20900, Italy|IRCCS Ospedale San Raffaele, Milano, MI, 20132, Italy|Ospedale San Gerardo ASST Monza Oncologia Medica, Monza, Monza AND Brianza, 20900, Italy|Azienda Ospedaliera Dei Colli, Naples, Napoli, 80131, Italy|Azienda Sanitaria Territoriale (AST) Pesaro Urbino, Pesaro, Pesaro AND Urbino, 61122, Italy|Centro Riferimento Oncologico di Aviano - IRCCS SOC Oncologia Medica e dei Tumori Immunocorrelati, Aviano, PN, 33081, Italy|Azienda Ospedaliero Universitaria di Parma, Parma, PR, 43126, Italy|A.O. Ospedali Riuniti Marche Nord - Presidio San Salvatore - Muraglia, Pesaro, PU, 61122, Italy|Azienda Ospedaliera San Camillo Forlanini, Roma, Rome, 00152, Italy|Istituto di Candiolo IRCCS - Fondazione del Piemonte per l'Oncologia, Candiolo, Torino, 10060, Italy|AOU San Luigi Gonzaga, Orbassano (TO), TO, 10043, Italy|AO Santa Maria della Misericordia, Perugia, Umbria, 06132, Italy|Azienda Ospedaliera San Giuseppe Moscati, Avellino, 83100, Italy|Policlinico "G. Rodolico", Catania, 95123, Italy|Ms Pneumed Janusz Milanowski, Katarzyna Szmygin-Milanowska Spolka Jawna, Lublin, 20-064, Poland|Elkardia Lubelskie Centrum Kardiologii, Lublin, 20-091, Poland|Centrum Medyczne Luxmed Sp. z o.o., Lublin, 20-504, Poland|Centrum Medyczne EVOMED, Szczecin, 70-382, Poland|Dom Lekarski Centrum Medyczne Outlet Park, Szczecin, 70-784, Poland|Pracownia Medycyny Nuklearnej, 109 Szpital Wojskowy z Przychodnia SP ZOZ, Szczecin, 70-965, Poland|Dom Lekarski S.A., Szczecin, 71-064, Poland|Samodzielny Publiczny Szpital Kliniczny Nr 1 im. prof. Tadeusza Sokolowskiego Pomorskiego UM, Szczecin, 71-252, Poland|Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, 28222, Spain|Hospital Teresa Herrera (C.H.U.A.C), A Coru?a, 15006, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, 08025, Spain|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, 08041, Spain|ICO L'Hospitalet (Hospital Duran i Reynals), L'Hospitalet de Llobregat, 08908, Spain|Hospital Universitario Ramon y Cajal, Madrid, 28034, Spain|Hospital Regional Universitario de Malaga, Malaga, 29010, Spain|Hospital Universitario Virgen del Rocio, Sevilla, 41013, Spain|Hospital Universitari i Politecnic La Fe, Valencia, 46026, Spain|Kantonsspital Graubuenden, Chur, Graubuenden, 7000, Switzerland|Guy's and St Thomas' NHS Foundation Trust, London, SE1 9RT, United Kingdom|NIHR/Wellcome Trust Clinical Research Facility, Manchester, M13 9WL, United Kingdom|The Christie NHS Foundation Trust, Manchester, M20 4BX, United Kingdom Less << |
NCT06282991 | Non-Small Cell Lung Carcinoma | COMPLETED | 2021-01-18 | CHANG GUNG MEMORIAL HOSPITAL K... More >>aohsiung Branch, Kaohsiung City, 83301, Taiwan|Chung Shan Medical University Hospital, Taichung, 402, Taiwan|Taichung Veterans General Hospital, Taichung, 407219, Taiwan|National Taiwan University Hospital, Taipei, 100, Taiwan|Taipei Veterans General Hospital, Taipei, 11217, Taiwan|Chang Gung Memorial Hospital - Linkou Branch, Taoyuan City, 333, Taiwan Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.46mL 0.49mL 0.25mL |
12.30mL 2.46mL 1.23mL |
24.61mL 4.92mL 2.46mL |